114942-83-5

Basic information

• Product Name: .+/-.-2-Methoxy-3,8-dioxocephalotax-1-ene
• Synonyms: .+/-.-2-Methoxy-3,8-dioxocephalotax-1-ene
• CAS NO: 114942-83-5
• Molecular Formula: C18H17NO5
• Molecular Weight: 327.33128
• Mol File: 114942-83-5.mol
• Article Data: 2

Chemical Properties

• Appearance: /
• CAS DataBase Reference: .+/-.-2-Methoxy-3,8-dioxocephalotax-1-ene(CAS DataBase Reference)
• NIST Chemistry Reference: .+/-.-2-Methoxy-3,8-dioxocephalotax-1-ene(114942-83-5)
• EPA Substance Registry System: .+/-.-2-Methoxy-3,8-dioxocephalotax-1-ene(114942-83-5)

Safety Data

• Hazardous Substances Data: 114942-83-5(Hazardous Substances Data)

Usage

Description

.+/-.-2-Methoxy-3,8-dioxocephalotax-1-ene, a member of the cephalotaxus alkaloids family, is a natural product derived from the Cephalotaxus species. It is recognized for its diverse biological activities, including anti-tumor, anti-inflammatory, and anti-microbial properties. .+/-.-2-Methoxy-3,8-dioxocephalotax-1-ene features a unique molecular structure with a bicyclic diterpenoid backbone, which contributes to its bioactive characteristics. Its potential pharmacological applications have garnered considerable attention in the fields of medicinal chemistry and drug development research, positioning it as a promising lead compound for the creation of novel pharmaceuticals.

Uses

Used in Pharmaceutical Development:
.+/-.-2-Methoxy-3,8-dioxocephalotax-1-ene is utilized as a lead compound in the pharmaceutical industry for its potential to develop new drugs. Its anti-tumor, anti-inflammatory, and anti-microbial properties make it a valuable asset in the search for novel therapeutic agents.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, .+/-.-2-Methoxy-3,8-dioxocephalotax-1-ene serves as a subject of study for understanding its bioactive properties and exploring its potential applications in the treatment of various diseases and conditions.
Used in Drug Delivery Systems:
Similar to gallotannin, .+/-.-2-Methoxy-3,8-dioxocephalotax-1-ene may benefit from the development of innovative drug delivery systems to enhance its efficacy and bioavailability. These systems could involve the use of organic or metallic nanoparticles as carriers, aiming to improve the compound's delivery and therapeutic outcomes in targeted applications.

Upstream product

• 1825-61-2 Trimethylmethoxysilane 
• 114956-74-0 2,3,8-trioxocephalotaxane 
• 121588-68-9 C₁₉H₂₁NO₆ 
• 121588-67-8 C₁₉H₂₃NO₆ 
• 40288-65-1 1-(benzo[1,3]dioxol-5-yl)-2-bromoethanone 
• 51099-55-9 5-ethoxy-3,4-dihydro-2H-pyrrole-2-carboxylic acid,ethyl ester 
• 121588-55-4 10,10a-dihydro-5H-[1,3]dioxolo[4',5':4,5]benzo[1,2-d]-pyrrolo[1,2-a]azepine-8,11(6H,9H)-dione 
• 121588-60-1 1-(2-Benzo[1,3]dioxol-5-yl-ethyl)-5-oxo-pyrrolidine-2-carboxylic acid 
• 121588-62-3 C₁₇H₁₇NO₄ 
• 121588-65-6 8,9-dihydro-4H-cyclopenta[a][1,3]dioxolo[4,5-h]pyrrolo[2,1-b][3]benzazepine-2,6(3H,5H)-dione 
• 121588-59-8 1-(2-Benzo[1,3]dioxol-5-yl-ethyl)-5-oxo-pyrrolidine-2-carboxylic acid ethyl ester 
• 121588-66-7 (+/-)-3-dehydroxy-2-demethoxy-1,2-dihydro-2,8-dioxocephalotaxine 
• 121588-61-2 C₁₇H₁₇NO₄ 
• 121588-63-4 10a-(2-oxopropyl)-10,10a-dihydro-5H-[1,3]dioxolo[4',5':4,5]benzo[1,2-d]pyrrolo[1,2-a]azepine-8,11(6H,9H)-dione 

Downstream Products

• 38848-21-4 (±)-cephalotaxine 

Relevant articles and documents

Total syntheses of (±)-cephalotaxine and (±)-8-oxocephalotaxine

-